cytori therapeutics inc (CYTX:NASDAQ GM)
E. Carmack Holmes M.D.
Director, Cytori Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 60 board members in 2 different organizations across 2 different industries.|
See Board Relationships
Dr. E. Carmack Holmes, MD served as the Surgeon-in-Chief of the University of California Los Angeles (UCLA) Medical Center since 1994 and holds the position of William P. Longmire, Jr. Professor and Chairman of Department of Surgery at UCLA School of Medicine. Dr. Holmes joined UCLA in 1973 and has held professorial positions in the Divisions of Cardiothoracic Surgery and Surgical Oncology for over 30 years. Dr. Holmes served as Vice Chairman of UCLA for five years prior ...
3020 Callan RoadPhone: 858-458-0900
San Diego, California 92121
Board Members Memberships*
University of North Carolina
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Dominick C. Colangelo Esq.||Chief Executive Officer, President, Treasurer and Director|
Aastrom Biosciences, Inc.
|Robin C. Stracey||Interim Chief Executive Officer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance & Nominating Committee|
Cesca Therapeutics Inc.
|Howard Zauberman||Chief Executive Officer, President and Director|
|Martin P. Rosendale||Chief Executive Officer and Director|
|Andrey Semechkin Ph.D.||Co-Chairman and Chief Executive Officer|
International Stem Cell Corporation
|$258.5K||Compensation as of Fiscal Year 2013.|